Sinil Pharm. Co., Ltd. manufactures generic prescription drugs with no patent protection.  The Company produces a variety of drugs including vitamins, mineral supplements, anti-inflammatory enzymes, liver disease, appetite stimulant, antihistamines, antispasmodics, and circulatory.

Outcomes of Annual Meeting of Shareholders

Submission of Audit Report

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Sinil Pharm (012790 KS)

Outcomes of Annual Meeting of Shareholders

Submission of Audit Report

Resolutions for Convocation of General Meeting of Shareholders

Decision on Cash Dividend and Dividend in Kind

Change of The Largest Shareholder

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)